Fanconi Anemia Pathway and Hematopoietic Dysfunction

Fanconi anaemia (FA) is a hereditary disorder marked by congenital anomalies, progressive bone marrow failure and a predisposition to malignancies. At its core lies the FA pathway, a concerted DNA repair network that resolves interstrand crosslinks (ICLs). Activation of the FA core complex leads to the monoubiquitination of FANCD2 and FANCI, recruiting downstream nucleases and homologous recombination factors. When this pathway is defective, genomic instability ensues, driving hypersensitivity to DNA crosslinking agents and depletion of haematopoietic stem cells (HSCs). The resulting pancytopenia and clonal evolution underpin the clinical spectrum of FA. Beyond canonical repair, FA proteins contribute to oxidative stress regulation, mitochondrial dynamics and inflammatory signalling, all of which influence HSC survival, self-renewal and transformation. Understanding these interconnected roles has paved the way for novel gene-therapy approaches, small-molecule modulators and antioxidant strategies to restore bone marrow function and prevent leukaemic progression.

Research from Nature Portfolio

Recent studies have revealed that polygenic interactions within the FA network intensify disease phenotypes. Mice harbouring hypomorphic mutations in both BRCA2 (FANCD1) and RAD51C (FANCO) faithfully recapitulate human FA, exhibiting severe bone marrow failure, profound replication stress and early tumour development. This work introduces a replication-stress paradigm in which co-occurring FANC gene defects synergise to amplify genomic instability. In another seminal study, elevated p53 activity was shown to downregulate a subset of FANC genes, diminishing interstrand crosslink repair capacity and exacerbating haematopoietic dysfunction. These findings position p53 not only as a detector of DNA damage but also as a critical regulator of FA pathway expression, underscoring a feedback loop that balances DNA repair with tumour-suppressive measures.

Fanconi Anemia Pathway and Hematopoietic Dysfunction publication trend

The graph below shows the total number of articles in fanconi anemia pathway and hematopoietic dysfunction across all publications each year (not limited to Nature Index journals).

Technical terms

DNA interstrand crosslink (ICL): A covalent linkage between complementary DNA strands that impedes replication and transcription.

Monoubiquitination: The attachment of a single ubiquitin molecule to a protein, altering its activity or cellular localisation.

Haematopoietic stem cells (HSCs): Multipotent cells within the bone marrow that generate all blood lineages.

Replication stress: Obstacles to DNA replication fork progression, leading to DNA damage and chromosomal instability.

Bone marrow failure: A pathological state in which haematopoietic tissue cannot sustain adequate blood cell production.

References

1. Hypomorphic Brca2 and Rad51c double mutant mice display Fanconi anemia, cancer and polygenic replication stress. Nature Communications (2023).
2. FANCA deficiency promotes leukaemic progression by allowing the emergence of cells carrying oncogenic driver mutations. Oncogene (2023).
3. Recent advances in understanding hematopoiesis in Fanconi Anemia. F1000Research (2018).
4. p53 downregulates the Fanconi anaemia DNA repair pathway. Nature Communications (2016).
5. Fancd2 in vivo interaction network reveals a non-canonical role in mitochondrial function. Scientific Reports (2017).